CK
CL icon

Carnick & Kubik’s Colgate-Palmolive CL Stock Holding History

Carnick & Kubik’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$677K Buy
9,578
+270
+3% +$18K 0.2% 137
2015
Q4 		$620K Buy
9,308
+423
+5% +$28.1K 0.4% 84
2015
Q3 		$564K Sell
8,885
-300
-3% -$19.6K 0.39% 93
2015
Q2 		$601K Sell
9,185
-275
-3% -$18.7K 0.49% 78
2015
Q1 		$656K Sell
9,460
-540
-5% -$37.3K 0.55% 67
2014
Q4 		$692K Buy
10,000
+535
+6% +$36.1K 0.59% 60
2014
Q3 		$617K Sell
9,465
-895
-9% -$59K 0.57% 63
2014
Q2 		$706K Buy
10,360
+85
+0.8% +$5.7K 0.7% 50
2014
Q1 		$667K Sell
10,275
-1,100
-10% -$69.3K 0.64% 54
2013
Q4 		$742K Sell
11,375
-2,435
-18% -$156K 0.67% 51
2013
Q3 		$819K Sell
13,810
-1,050
-7% -$62.2K 1.25% 25
2013
Q2 		$851K Buy
+14,860
New +$882K 1.05% 37

Other funds holding CL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Carnick & Kubik's CL Position: Q1 2016 in Review

Carnick & Kubik increased its Colgate-Palmolive (CL) stake by 2.9% in Q1 2016, buying an estimated $18K and bringing the position to 9,578 shares worth $677K. The position accounts for 0.2% of the portfolio, ranked #137.

Carnick & Kubik first reported a position in CL in Q2 2013 and has held it in 12 quarters since. The position peaked at $851K in Q2 2013. 1,262 funds tracked by Wall St. Rank hold CL as of Q1 2016.

  • Carnick & Kubik held 9,578 shares of Colgate-Palmolive worth $677K as of Q1 2016.
  • Carnick & Kubik bought 270 Colgate-Palmolive shares in Q1 2016, an estimated $18K.
  • Colgate-Palmolive made up 0.2% of Carnick & Kubik's portfolio in Q1 2016, its #137 holding.
  • Carnick & Kubik first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 12 quarters since.
  • Carnick & Kubik's Colgate-Palmolive position peaked at $851K in Q2 2013.
  • 1,262 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.